Finite element modeling with patient‐specific geometry to assess clinical risks of percutaneous pulmonary valve implantation

Abstract

AbstractBackgroundPercutaneous pulmonary valve implantation (PPVI) is a non‐surgical treatment for right ventricular outflow tract (RVOT) dysfunction. During PPVI, a stented valve, delivered via catheter, replaces the dysfunctional pulmonary valve. Stent oversizing allows valve anchoring within the RVOT, but overexpansion can intrude on the surrounding structures. Potentially dangerous outcomes include aortic valve insufficiency (AVI) from aortic root (AR) distortion and myocardial ischemia from coronary artery (CA) compression. Currently, risks are evaluated via balloon angioplasty/sizing before stent deployment. Patient‐specific finite element (FE) analysis frameworks can improve pre‐procedural risk assessment, but current methods require hundreds of hours of high‐performance computation.MethodsWe created a simplified method to simulate the procedure using patient‐specific FE models for accurate, efficient pre‐procedural PPVI (using balloon expandable valves) risk assessment. The methodology was tested by retrospectively evaluating the clinical outcome of 12 PPVI candidates.ResultsOf 12 patients (median age 14.5 years) with dysfunctional RVOT, 7 had native RVOT and 5 had RV‐PA conduits. Seven patients had undergone successful RVOT stent/valve placement, three had significant AVI on balloon testing, one had left CA compression, and one had both AVI and left CA compression. A model‐calculated change of more than 20% in lumen diameter of the AR or coronary arteries correctly predicted aortic valve sufficiency and/or CA compression in all the patients.ConclusionAgreement between FE results and clinical outcomes is excellent. Additionally, these models run in 2–6 min on a desktop computer, demonstrating potential use of FE analysis for pre‐procedural risk assessment of PPVI in a clinically relevant timeframe.